Contineum Therapeutics Updates Corporate Presentation

What Happened Contineum Therapeutics, Inc. (CTNM) filed a Form 8‑K on July 13, 2026 under Item 7.01 (Regulation FD Disclosure) to announce an updated corporate presentation reflecting business and strategic updates. The updated presentation is attached to the filing as Exhibit 99.1 and will be posted on the company’s website at www.contineum-tx.com. The filing was signed by Peter Slover, Chief Financial Officer.

Key Details

• Date filed: July 13, 2026.
• Updated corporate presentation attached as Exhibit 99.1 to the Form 8‑K.
• Presentation will be posted at www.contineum-tx.com and used for future updates.
• Company stated it does not intend to file a Form 8‑K every time the presentation is updated.

Why It Matters An updated corporate presentation can include material business or strategic information that investors use to assess the company’s direction. By posting updates on its website rather than filing a separate 8‑K each time, Contineum signals investors should monitor its website for the latest presentation content to stay informed of changes.